Aviva Invests in Owlstone Medical Breath Biopsy Platform
28 March 2017
Owlstone Medical Ltd, a diagnostics company developing a breathalyzer for disease, today announced an investment from Aviva Ventures, the venture capital arm of Aviva plc
Thank you for your interest in publishing press release with pulp & paper. Our client success team member will get in touch with you shortly to take this ahead. While you're here, check out our informative and insightful press releases. Happy Surfing!
Regards,
Client Success Team (CRM),
Successfully repored......
Regards,
Client Success Team (CRM),
28 March 2017
Owlstone Medical Ltd, a diagnostics company developing a breathalyzer for disease, today announced an investment from Aviva Ventures, the venture capital arm of Aviva plc
